2007XceleratedProfitsPortfolioUpdateArchive
2007 Archives | 2006 Archives
12/28/2007 – TRADE ALERT: Close Out Your Bank Of America Put Position
Due to the increasing mess in the subprime markets and the exposure that some of the American banks have, we’re going to close out our January 2008 $45 naked put option that we have in Bank of America (NYSE: BAC). As 2007 comes to a close, the turbulence rumbles on
12/14/2007 – Profit Alert: Sell Half Your BioMarin Position For A 99% Gain
As expected, BioMarin’s (Nasdaq: BMRN) new Kuvan was approved without a problem yesterday. And shares are responding to the news in stunning fashion
12/13/2007 – You Asked The Questions We Provide The Answers: More Guidance On Our Positions
Along with catalogs, cards, and shopping offers, the mailmen and e-mail servers have had an even busier load, thanks to the great feedback and questions that Xcelerated Profits Report readers keep sending. Many thanks for taking the time to write..
12/11/2007 – PROFIT ALERT: Lock In 16% Gains On Wal-Mart January 2008 Puts
Back in our June 2007 issue, I recommended a “naked put” on the Wal-Mart (NYSE: WMT January 2008 $42.50 put options (WMT-MV). This is a good way to buy shares for less money
11/29/2007 – From “Black Friday” To “Cyber Monday” ‘Tis The Time For Retail
As I looked at the performance of the XPR portfolio yesterday, it was certainly good to see every position showing green numbers. And not just edging into the green either. Many finished up significantly, feeding off one of the stock market’s big rally days
11/21/2007 – Three Portfolio Rules And Our Position Rundown
I know it’s pretty dismal out there. Many investors will head off into the Thanksgiving holiday licking their wounds after a brutal month
11/16/2007 – L-3 Goes To Space Pfizer Dumps A Laggard And Adds A Leader Plus New Guidance On Cynosure
Let’s kick off by playing a little defense. And when we talk about defense, that means one company: L-3 Communications (NYSE: LLL). Amid a bevy of market strife, this defense sector giant continues to
11/09/2007 – Accuray’s Record-Breaking Quarter And A Pro Strategy Payoff On Cynosure
Once again, we’re bringing you an end-of-the-week wrap-up to dissect Accuray’s (Nasdaq: ARAY) important quarterly earnings report from yesterday, as well as updating you on our most recent biotech recommendation
10/25/2007 – Good Riddance To Europe, As Microsoft Abandons Its Legal Battles
It’s finally over For many folks, Europe is a pleasant place to visit. The history. The culture. The people. But I imagine Microsoft (Nasdaq: MSFT) is sick of the place. For a decade now
10/10/2007 - eBay Creates Community Spirit Through Commerce
These days, the World Wide Web is all about social networking. And as the Internet evolves, companies that rely on the medium for their business are forced to either adapt or fail
10/03/2007 - A Mad Guy With His “Mad Money” Gives BioMarin A Healthy Boost
Say what you want about Jim Cramer, but there’s no doubt that he has the ability to move stocks if he wants to. All it takes is a bullish shout (literally!) on his popular CNBC show “Mad Money,” and the masses will
09/27/2007 - Accuray Rebounding Strongly And Gorging On Positive Analyst Vibes
After a difficult six weeks, our cutting-edge healthcare equipment firm Accuray (Nasdaq: ARAY) appears to be back on track
09/20/2007 - Fed Rides To The Rescue But What Now For The Battered Greenback?
The Federal Reserve finally made the move the market craved this week, slashing the federal funds interest rate not by 0.25%, but by a larger than expected 0.5% – from 5.25% to 4.75%. Good news for the markets and for our portfolio. But bad news for our standard of living. And even worse for the
09/12/2007 - Mylan Motors Its Way To Multiple Drug Approvals
Drugs, drugs and more drugs! Or, to put it more specifically, drug approvals. That’s the story for Mylan Laboratories (NYSE: MYL) recently. The company seems to have had a direct hotline to the Food & Drug Administration regarding
08/29/2007 - Can You Profit In A Topsy-Turvy Market? You Bet
Feeling queasy? No, I’m not talking about the sultry summer heat getting to you. I’m talking about our old friend – the stock market. After Tuesday’s 281-point drop on the Dow, the index changed course again today, shooting back up by
08/23/2007 - Ragged Market Takes A Breather Here’s Our Latest Guidance On Two Positions
After last week’s tumultuous activity, the stock market has thankfully returned to some kind of relative normalcy this week. With the Fed having pumped a substantial amount of cash into the market to boost liquidity, as well as cutting the discount rate by
08/17/2007 - Zapping Tumors And Scooping Cash Accuray Posts Record Quarterly Revenue AndBacklog
Last night, Accuray (Nasdaq: ARAY) reported its fiscal fourth-quarter results – and the numbers were very pleasing.
08/16/2007 - The China FXI Trade A Profit Post-Mortem
In response to a few questions we’ve received on our China recommendation – the put option play on the iShares FTSE/Xinhua China 25 Index (NYSE: FXI) – I’d like to explain the reasoning behind why we exited the position early.
08/15/2007 - Big Day For Accuray And The Earnings Report Will Reveal The Details
One of our newest and most promising recommendations, Accuray (Nasdaq: ARAY), reports its quarterly earnings after the market closes tomorrow.
08/15/2007 - We’re Up Over 40% On FXI Here’s Your Next Move
Our put option play on the iShares FTSE/Xinhua China 25 Index (NYSE: FXI) are up over 40% in just a couple of months
08/09/2007 - Special Update: The Markets Just Got Crushed, But You’ll Sleep Safe Tonight
Suffice it to say, today was not a good day for many investors. With the sub-prime mortgage mess spilling over into Europe, the major exchanges over there were already taking a beating before U.S. investors even woke up. The Dow, Nasdaq and S&P then
08/08/2007 - Huge News For Our Healthcare Stocks Accuray And BioMarin Head Higher
Every year, you can bet that lazy financial reporters will note how the stock market usually takes a nap during the summer months. But listen to the deafening silence from those folks now
08/06/2007 - With 45% Gains In The Bag, Cancel The Remaining Trade On BP Shares
Let’s start the week with an update on our current BP (NYSE: BP) position In the May issue, I recommended a 50% position in BP at $67.25, while also buying the January 2008 $55 calls (BP-AK) at the same time
08/01/2007 - BigBand Sings The Blues But Here’s What To Expect From Immersion Earnings
The current market volatility isn’t really a surprise. A pullback or even a more pronounced correction is long overdue. But it’s resulted in our portfolio suffering its first loss in a very long time – on a most inopportune day, too
07/26/2007 - FDA Grants BioMarin “Priority Review Status” For Kuvan
In yesterday’s Portfolio Update, we reported that the FDA was set to announce whether it would grant BioMarin “priority review status” for its new drug, Kuvan. Just a few hours later, we got the news we wanted
07/25/2007 - Alert: FDA Expected To Report On New BioMarin Drug Today
Today could be a very important day for BioMarin Pharmaceuticals (Nasdaq: BMRN) – our recommendation in the August issue. Our new Senior Analyst made the pick, and has all the details for you
07/18/2007 - A 77% Winner That’s Lighting Up Towers And Set To Blast Higher
In the December 2006 issue, we issued a recommendation on Color Kinetics (Nasdaq: CLRK). The company is taking huge strides in LED lighting – the tiny light bulbs that have taken
07/11/2007 - Coeur d’Alene And BigBand Blast Higher And UNOR Could Be Next
Let’s take a break from the mailbag today and run with some good news on three of our positions, starting with our silver recommendation, Coeur d’Alene Mines (NYSE: CDE)
07/06/2007 - This Small-Cap Is Living Large And Handing Us 178%
You’ve probably seen reports this week, citing the short week and July 4 holiday for lower trading volumes and relatively uneventful activity. But it certainly didn’t stop one stock from blasting
07/05/2007 - Sell Your BP Calls For A 45% Gain
Hope you had a good July 4. Now let’s restart the week with a fat winner In the May issue, I recommended you take a position in BP plc (NYSE: BP)
06/29/2007 – Bigband Networks
BigBand (Nasdaq: BBND) has had quite a ride in the markets today. We’re down about 28% on the position ($18.25 entry) and very close to stopping out. Luckily, it closed at $13.07 at the end of day.
06/28/2007 - XPR Portfolio Update
Accuray (NASDAQ: ARAY) is presenting at a healthcare conference today. The presentation is scheduled to be carried “live” on its website. You can accessitby
06/27/2007 - The XPR Mailbag – Part III
Want to know which of our recommendations to buy? Our latest take on cancer treatment firm Accuray (Nasdaq: ARAY) or uranium company Unor (OTC: UNOFF:PK)? Want to know where to find a good broker? Keep reading
06/22/2007 - Sell ACAS
Sell your American Capital Asset Strategies (Nasdaq: ACAS) shares and lock in your gains
06/21/2007 - ACAS Trading Under $44 Be Ready To Protect Your Profits
Keep a close eye on American Capital Strategies (Nasdaq: ACAS) today. On Wednesday, the stock closed at $44.02 – just a hair above our trailing-stop point of
06/21/2007 - The XPR Mailbag – Part II
We greatly appreciate you taking the time to write to us. This is your service, and it gives us invaluable feedback. We also aim to communicate with you as much as possible. So here’s Part II
06/19/2007 - Color Kinetics Up More Than 76% on News of Sale
Chalk up another Xcelerated profit for your portfolio. This morning we got great news when the world’s largest lighting company, Royal Philips Electronics NV, announced an offer of about $688 million to buy
06/13/2007 - The XPR Mailbag – Part I
In response to a flood of e-mails, I’m going to spend the next few columns answering a few of your questions. Many of you have brought up issues and comments that apply to all subscribers, so many thanks for writing in. Keep ‘em coming – we’ll do our best to answer as many of your e-mails as possible here. Let’s get started
06/07/2007 - The Markets Are Falling, But We’re Holding Steady
The sell-off in the market yesterday and today is unnerving. And it may sell off some more in the next few days and weeks. This is not unusual. Markets and stocks correct
06/07/2007 - The Triple-Digit Tactile Profit Shakedown
How about a triple-digit winner? In case you missed it on Monday, we issued a partial sell recommendation on our Immersion Corp (Nasdaq: IMMR) position
06/04/2007 - Portfolio Update: Take Partial Profits In Immersion
Immersion (Nasdaq: IMMR) has been very good for our portfolio. There is nothing but good news coming out of the company. We’re up over 100% from our original entry price
05/24/2007 - Hitting The Highs And Grabbing The Gains: L-3 And eBay Blast Forward
Seen the performance of L-3 Communications (NYSE: LLL) recently? Shares shot up to a 52-week high of $95.67 on May 10 and are currently trading just over $93
05/16/2007 - A Small-Cap Stock With Big Time Profit Potential
When is a selloff actually a sign of strength? When it comes to small-cap uranium company UNOR. If you remember, we entered this position as part of a “doubleheader” play with uranium heavyweight
05/10/2007 - Blistering Gains For The XPR Portfolio And Great Earnings, Too
First, I would like to let you know that three of the XPR portfolio’s positions have just hit 52-week highs! They are
05/03/2007 - Portfolio Update: Buy Back Your ICE Options For A 17% Gain
In the April issue, we recommended selling September 2007 $85 put options (ICE-UQ) for
05/02/2007 - Urgent Update: Time To Get Into BP
Before we plow into a crucial week of earnings reports for the companies in our portfolio, I’ve got some late-breaking news from Xcelerated Profits Report technical analyst Jim Stanton on his recommendation in the May issue
04/25/2007 - A Quartet Of Earnings And A Big Week For Our Portfolio
With the first quarter of 2007 in the rear-view mirror, the bean-counters at America’s publicly traded companies are busy crunching the numbers and are set to release their latest earnings reports. It’s always a hectic period – one that can move the markets significantly, so we need to be aware of what’s in the pipeline
04/20/2007 - Immersion Continues To Rumble On
There’s one position in our portfolio that continues to blast ahead with gusto. Since we entered the position on December 1, 2005, we’re currently up
04/11/2007 - Mr. Softie Takes China, and Royal Navy News For The APR
It seems like every time you turn on the news, there’s a story about China. The country’s GDP growth is expanding at 9.7% clip. China holds $1 trillion in foreign currency reserves
04/05/2007 - Color Kinetics Surges On Yet Another Deal And Accuray Enters The 2,000 Club
The deals keep on rolling in for LED industry leader. This is a company we added to the portfolio in the December 2006 issue
03/28/2007 - “Three For Three” On L-3 And eBay With A Potential 185% Gain Waiting In The Wings
If you’ve been watching the performance of L-3 Communications (NYSE: LLL) shares over the past couple of weeks, you’ll know that the stock has risen pretty impressively – from
03/21/2007 - Key Event For Microsoft Could See Renewed Buying Activity
Incorporating some form of technical analysis into your investment decisions is a key factor in whether or not you’ll get the most out of your trades and become a successful investor. At the Xcelerated Profits Report, our team of
03/15/2007 - eBay On The Profit Track, While Immersion Hits The “Popular” News
While the rest of the investment world buys shares at “face value,” there’s one powerful technique that allows you to beat them and buy your shares at a discount instead. It’s known as the covered call strategy, where you sell a company’s options
03/07/2007 - Pocket A 19.7% Win On PICO And Follow The Insiders To ACAS
If you’re not already employing trailing stops on your positions that are rising, here’s a great example of why you should be doing so Back in the February 7 XPR Insight, we gave you this instruction, regarding our portfolio member PICO
03/01/2007 – APR Portfolio Holding Steady Despite Market Horror Show
Tuesday’s widespread market selloff was a wake-up call for many investors, with the Dow’s 416-point plunge serving as a particularly timely reminder to many that markets go down as well as up. The Volatility Index (VIX) – a measure of market
02/22/2007 - Why Ballmer’s “Buzz Kill” And Watts’ Weakening Could Actually Bode Well
It’s hard to believe that one simple blog post can damage a stock with a $285 billion market cap. But in today’s technocentric society, it’s very possible. Last week, Microsoft (Nasdaq: MSFT) CEO Steve Ballmer was overheard in an
02/07/2007 - A New Trailing Stop For Pico, While Sony’s Star Witness Is Snubbed
In the January issue, we introduced you to PICO Holdings (Nasdaq: PICO) – a “mini Berkshire-Hathaway” of a company involved in water rights deals all across the southwestern United States. With the region in the midst of
01/31/2007 - How to Beat Earnings – Even With $1.6 Billion Dollars Missing
There are very few companies on the face of this planet that can miss $1.6 billion in sales – yet still beat Wall Street earnings expectations. But our portfolio member Microsoft (Nasdaq: MSFT) is one of the few that can. No matter what.
01/24/2007 - ACAS Adds Another, While Immersion “Feels” Good Vibe From Patents
There’s no doubt about it American Capital Strategies (Nasdaq: ACAS) is on a tear. Since recommending the stock in the July 2006 issue, we’re up a massive
01/18/2007 - The Immersion vs. Sony Saga: What You Need To Know
The Sony-Immersion lawsuit saga continues to rumble on As you probably know by now, the case in currently in the U.S. Court of Appeals – and a ruling could come any day now
01/10/2007 - PICO Begins Its Rise As Insiders Pile In
It’s just over two weeks now since my PICO Holdings (Nasdaq: PICO) recommendation in the January issue became a live trade – and we’re currently sitting on a small gain from our entry price. That’s a decent start – but we think
01/05/2007 - Will REITs Run Again?
This time last year, economists were quick to bark that 2006 would be the year red-hot real estate investment trusts (REITs) fizzled. And once again, we have reason to largely ignore such predictions
01/03/2007 - Three Gainers And A Big Decision Imminent
We’re still awaiting a final decision in on Immersion’s (Nasdaq: IMMR) patent infringement lawsuit against Sony – a decision that is expected any day now. Back on October 3, the two companies met in Washington, D.C
2007 Archives | 2006 Archives